ProShare Advisors’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $370K | Sell |
|
|||||
|
2025
Q1 | $448K | Sell |
|
|||||
|
2024
Q4 | $499K | Buy |
|
|||||
|
2024
Q3 | $251K | Buy |
|
|||||
|
2024
Q2 | $165K | Sell |
|
|||||
|
2024
Q1 | $208K | Buy |
|
|||||
|
2023
Q4 | $61.8K | Buy |
|
|||||
|
2023
Q3 | $56.9K | Buy |
|
|||||
|
2023
Q2 | $102K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $154K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $200K | Sell |
|
|||||
|
2021
Q4 | $272K | Sell |
|
|||||
|
2021
Q3 | $341K | Sell |
|
|||||
|
2021
Q2 | $442K | Buy |
|
|||||
|
2021
Q1 | $380K | Buy |
|
|||||
|
2020
Q4 | $318K | Buy |
|